TScan Therapeutics Reports Q2 2026 Financial Results

What Happened

• TScan Therapeutics, Inc. (TCRX) announced its financial results for the second quarter ended June 30, 2026 via a press release dated August 12, 2026. The release was furnished as Exhibit 99.1 to the Current Report on Form 8-K (Item 2.02). The company expressly states the furnished material is “furnished” — not “filed” — and is not automatically incorporated by reference into other securities filings.

Key Details

• Event: Financial results/quarterly earnings announcement (Item 2.02).
• Date filed: August 12, 2026; quarter ended: June 30, 2026.
• Exhibit: Press release furnished as Exhibit 99.1 to the Form 8-K.
• Legal note: Information furnished is not subject to Section 18 liability and is not incorporated by reference into other filings unless specifically referenced.

Why It Matters

• Retail investors should review the furnished press release (Exhibit 99.1) for the company’s reported revenues, expenses, net loss/profit, cash position, and any operational updates that could affect the stock. The Form 8-K confirms the timing and legal status of the disclosure but does not itself include the numerical details — those are in the attached press release.